Daniel G Schwartz, MD | |
601 Broadway Ste 600, Seattle, WA 98122-5330 | |
(206) 386-6171 | |
(206) 860-6634 |
Full Name | Daniel G Schwartz |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 18 Years |
Location | 601 Broadway Ste 600, Seattle, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003063165 | NPI | - | NPPES |
2033975 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | MD60411696 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Swedish Medical Center | Seattle, WA | Hospital |
Swedish Medical Center / Cherry Hill | Seattle, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Swedish Health Services | 0244138196 | 834 |
News Archive
Federal officials said Friday that the trend toward relatively low premium charges and stable benefits will likely continue.
Aruba Networks, Inc., a global leader in 802.11n wireless LANs and secure mobility solutions, today announced that the University Hospital of South Manchester NHS Foundation Trust in the United Kingdom is using Aruba's Virtual Branch Networking (VBN) solution to increase the quality of antenatal services delivered to the local community.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of AvastinĀ® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.
Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine is more effective at preventing life-threatening complications following a percutaneous coronary intervention (PCI) (angioplasty, stenting) on patients who have undergone previous bypass surgery than distal protection devices alone.
› Verified 7 days ago
Entity Name | Swedish Health Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689612954 PECOS PAC ID: 0244138196 Enrollment ID: O20031230000187 |
News Archive
Federal officials said Friday that the trend toward relatively low premium charges and stable benefits will likely continue.
Aruba Networks, Inc., a global leader in 802.11n wireless LANs and secure mobility solutions, today announced that the University Hospital of South Manchester NHS Foundation Trust in the United Kingdom is using Aruba's Virtual Branch Networking (VBN) solution to increase the quality of antenatal services delivered to the local community.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of AvastinĀ® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.
Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine is more effective at preventing life-threatening complications following a percutaneous coronary intervention (PCI) (angioplasty, stenting) on patients who have undergone previous bypass surgery than distal protection devices alone.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Daniel G Schwartz, MD Po Box 25608, Salt Lake City, UT 84125-0608 Ph: (206) 320-4476 | Daniel G Schwartz, MD 601 Broadway Ste 600, Seattle, WA 98122-5330 Ph: (206) 386-6171 |
News Archive
Federal officials said Friday that the trend toward relatively low premium charges and stable benefits will likely continue.
Aruba Networks, Inc., a global leader in 802.11n wireless LANs and secure mobility solutions, today announced that the University Hospital of South Manchester NHS Foundation Trust in the United Kingdom is using Aruba's Virtual Branch Networking (VBN) solution to increase the quality of antenatal services delivered to the local community.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of AvastinĀ® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.
Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine is more effective at preventing life-threatening complications following a percutaneous coronary intervention (PCI) (angioplasty, stenting) on patients who have undergone previous bypass surgery than distal protection devices alone.
› Verified 7 days ago
Karina Marie Katchko, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Mr. Bahman Sahranavard Sr., MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-520-5000 | |
Dr. Sean D Toomey, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Broadway, Seattle, WA 98122 Phone: 206-386-2600 Fax: 206-622-1644 | |
Dr. Wayne M Weil, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2409 N 45th St, Seattle, WA 98103 Phone: 206-633-8100 Fax: 206-633-6107 | |
Robert Paul Dunbar Jr., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Harborview Medical Center, 325 9th Ave, Seattle, WA 98104 Phone: 206-731-3462 | |
Christopher P Cannon, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Broadway Ste 600, Seattle, WA 98122 Phone: 206-386-6171 Fax: 206-860-6634 |